1,537
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparison of embryo quality and pregnancy outcomes for patients with low ovarian reserve in natural cycles and mildly stimulated cycles: a cohort study

, , , , , , , , & ORCID Icon show all
Article: 2303693 | Received 29 Mar 2023, Accepted 26 Dec 2023, Published online: 23 Jan 2024

References

  • Ata, B., et al., 2008. Embryo implantation rates in natural and stimulated assisted reproduction treatment cycles in poor responders. Reproductive Biomedicine Online, 17 (2), 207–212.
  • Conforti, A., et al., 2019. Management of women with an unexpected low ovarian response to gonadotropin. Frontiers in Endocrinology, 10, 387.
  • De Marco, M. P., et al., 2021. Natural cycle results in lower implantation failure than ovarian stimulation in advanced-age poor responders undergoing IVF: fertility outcomes from 585 patients. Reproductive Sciences , 28 (7), 1967–1973.
  • Di Guardo, F., et al., 2022. Poor ovarian response and the possible role of natural and modified natural cycles. Therapeutic Advances in Reproductive Health, 16, 26334941211062026.
  • DiMattina, M., et al., 2014. Follicular and estradiol parameters that improve success with natural cycle in vitro fertilization. J Reprod Med, 59, 267–273.
  • Drakopoulos, P., et al., 2019. Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders. Reproductive Biomedicine Online, 39 (4), 698–703.
  • Elizur, S. E., et al., 2005. Modified natural cycle using GnRH antagonist can be an optional treatment in poor responders undergoing IVF. Journal of Assisted Reproduction and Genetics, 22 (2), 75–79.
  • Fields, E.,., et al., 2013. Fertility (update): summary of NICE guidance. BMJ (Clinical Research ed.), 346 (1), f650–f650. and
  • Højgaard, A., Ingerslev, H. J. and Dinesen, J., 2001. Friendly IVF: patient opinions. Human Reproduction , 16 (7), 1391–1396.
  • Ingerslev, H. J., et al., 2001. A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate. Human Reproduction , 16 (4), 696–702.
  • Jirge, P. R., 2016. Poor ovarian reserve. Journal of Human Reproductive Sciences, 9 (2), 63–69.
  • Joshi, N., et al., 2012. Trends and correlates of good perinatal outcomes in assisted reproductive technology. Obstetrics and Gynecology, 120 (4), 843–851.
  • Kamel, R. M., 2010. Management of the infertile couple: an evidence-based protocol. Reproductive Biology and Endocrinology, 8 (1), 21.
  • Kaneko, T., et al., 2000. Effects of controlled ovarian hyperstimulation on oocyte quality in terms of the incidence of apoptotic granulosa cells. Journal of Assisted Reproduction and Genetics, 17 (10), 580–585.
  • Kedem, A., et al., 2014. Is the modified natural in vitro fertilization cycle justified in patients with “genuine” poor response to controlled ovarian hyperstimulation? Fertility and Sterility, 101 (6), 1624–1628.
  • Kim, C. H., et al., 2009. Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility, 92 (6), 2082–2084.
  • Kolibianakis, E., et al., 2004. Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Human Reproduction , 30 (10), 2321–2330.
  • Lainas, T. G., et al., 2015. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders. Human Reproduction, 30 (10), 2321–2330.
  • Lindheim, S. R., et al., 1997. Poor responders to ovarian hyperstimulation may benefit from an attempt at natural-cycle oocyte retrieval. Journal of Assisted Reproduction and Genetics, 14 (3), 174–176.
  • Lindsay, T. J. and Vitrikas, K. R., 2015. Evaluation and treatment of infertility. Am Fam Physician, 91, 308–314.
  • Mahutte, N. G. and Arici, A., 2007. Role of gonadotropin-releasing hormone antagonists in poor responders. Fertility and Sterility, 87 (2), 241–249.
  • Morgia, F., et al., 2004. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertility and Sterility, 81 (6), 1542–1547.
  • Munne, S., et al., 1997. Treatment-related chromosome abnormalities in human embryos. Human Reproduction , 12 (4), 780–784.
  • Ng, E. H., et al., 2001. In vitro fertilization and embryo transfer during natural cycles. The Journal of Reproductive Medicine, 46 (2), 95–99.
  • Pelinck, M. J., et al., 2002. Efficacy of natural cycle IVF: a review of the literature. Human Reproduction Update, 8 (2), 129–139.
  • Phillips, S. J., et al., 2007. Controlled natural cycle IVF: experience in a world of stimulation. Reproductive Biomedicine Online, 14 (3), 356–359.
  • Polyzos, N. P., et al., 2012. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Human Reproduction, 27 (12), 3481–3486.
  • Practice Committee of the American Society for Reproductive, Medicine. 2015. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril, 103, e44-50.
  • Rasool, S. and Shah, D., 2017. Fertility with early reduction of ovarian reserve: the last straw that breaks the Camel’s back. Fertil Res Pract, 3, 15.
  • Schimberni, M., et al., 2009. Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles. Fertility and Sterility, 92 (4), 1297–1301.
  • Van Blerkom, J. and Davis, P., 2001. Differential effects of repeated ovarian stimulation on cytoplasmic and spindle organization in metaphase II mouse oocytes matured in vivo and in vitro. Human Reproduction, 16 (4), 757–764.
  • von Wolff, M., 2019. The role of natural cycle IVF in assisted reproduction. Best Practice & Research. Clinical Endocrinology & Metabolism, 33 (1), 35–45.
  • Ziebe, S., et al., 2004. Embryo quality in natural versus stimulated IVF cycles. Human Reproduction , 19 (6), 1457–1460.